Otros idiomas Waters Corporation London S.E.

Acciones

0LTI

US9418481035

Mercado cerrado - London S.E. Otros sitios de cotización 16:08:18 14/06/2024			Varia. Cinco días.	Varia. 1 de enero.
291,3 ^USD	-1,42 %		-3,14 %	-11,28 %

05/06	Transcript : Waters Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM
29/05	Un iniciado de Waters compro acciones por valor de 332.900 dolares, segun un reciente registro de la SEC	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

ÖBAG verkauft Vamed-Beteiligung an Fresenius	04/06
Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass Spectrometer	03/06
Waters Becomes First Liquid Chromatography Column Provider to Receive My Green Lab ACT Ecolabel Certification	03/06
Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing	29/05
Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing	16/05
Waters Corporation to Present at the Jefferies 2024 Healthcare Conference	13/05
Waters ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument	08/05
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	08/05
Waters Seeks M&A Opportunities	07/05
Waters' Q1 Non-GAAP Earnings, Net Sales Decline; Q2 Outlook Issued	07/05
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Revenue $636.8M	07/05
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Adjusted EPS $2.21	07/05
Waters: Q1 Earnings Snapshot	07/05
Waters : Q1 2024 Non-GAAP	07/05
Waters Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results	07/05
Waters Corporation Reports Earnings Results for the First Quarter Ended March 30, 2024	07/05
Waters Corporation Provides Earnings Guidance for the Second Quarter Ending June 29, 2024 and Full Year Ending December 31, 2024	07/05
Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns	22/04
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call	11/04
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors	09/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Waters Corporation London S.E.

Acciones

0LTI

US9418481035

Otros idiomas

Filtros